Products now available for sale in medical
channel through new ecommerce platform
VAUGHAN, ON, Jan. 8, 2021 /CNW/ - CannTrust Holdings Inc.
("CannTrust" or the "Company") announces it is re-entering the
Canadian medical cannabis market today with its new medical brand
estoraTM and will begin serving patients
immediately.
estoraTM builds on CannTrust's foundation of
consistent, high quality products, with a focus on providing
superior patient care in every interaction, connecting patients,
health care practitioners and partners with the educational
resources and products they need to navigate each patient's unique
medical cannabis journey.
"Since our inception, we have been dedicated to providing
Canadians with consistently high-quality medical cannabis," said
Greg Guyatt, Chief Executive Officer
at CannTrust. "We're delighted to be launching our new medical
brand estoraTM with a portfolio of medical
cannabis products including oil drops, capsules and dried flower
formats."
Many products are available for sale immediately through the
newly launched ecommerce site www.estoramedical.com.
"We believe it was imperative to evolve our strong foundation in
medical cannabis to meet the changing needs of our patients," said
Guyatt. "estora™ has patient care at its core. We consulted
patients and health care practitioners, learning more about their
needs and refining our processes and product offerings to elevate
their experience with us."
CannTrust remains under CCAA protection to facilitate its
efforts to resolve its civil litigation claims and complete its
review of strategic alternatives. These efforts are ongoing and
confidential, and the Company is unable to predict either their
timing or their outcome. In the meantime, with the reinstatement of
its cannabis licenses and the ongoing restoration of its
operations, CannTrust's re-entry into the medical cannabis business
segment is an important part of its focus on rebuilding trust by
delivering quality, innovative products to its patients and
customers. For more information about CannTrust's CCAA proceedings,
please visit: www.ey.com/ca/canntrust.
About estoraTM
estoraTM is a Canadian medical cannabis
brand. Our portfolio has been designed with patients in mind, with
easy-to-use formats and standardized processes, that ensure
consistency and quality in every bottle. We're not just
a medical cannabis provider, but a partner, providing
guidance and support for our patients on their journey with medical
cannabis, so they can focus on what's really
important.
estoramedical.com
@estoramedical
Forward-Looking Statements
This press release contains "forward-looking information" within
the meaning of Canadian Securities laws and "forward-looking
statements" within the meaning of the United States Private
Securities Litigation Reform Act of 1995 and other applicable
United States safe harbor laws,
and such statements are based upon CannTrust's current internal
expectations, estimates, projections, assumptions and beliefs and
views of future events.
Forward-looking information and forward-looking statements can
be identified by the use of forward-looking terminology such as
"believes", "expect", "likely", "may", "will", "should", "intend",
"anticipate", "potential", "proposed", "estimate" and other similar
words, including negative and grammatical variations thereof, or
statements that certain events or conditions "may", "would" or
"will" happen, or by discussions of strategy.
Forward-looking information and statements necessarily involve
known and unknown risks, including, without limitation: the outcome
of the Company's contingent liabilities; the impact of potential
regulatory investigations; the Company's review of strategic
alternatives; risks associated with general economic conditions;
adverse industry events; loss of markets; future legislative and
regulatory developments in Canada,
the United States and elsewhere;
the cannabis industry in Canada
generally; and, the ability of CannTrust to implement its business
strategies.
Any forward-looking information and statements speak only as of
the date on which they are made, and, except as required by law,
CannTrust does not undertake any obligation to update or revise any
forward-looking information or statements, whether as a result of
new information, future events or otherwise. New factors emerge
from time to time, and it is not possible for CannTrust to predict
all such factors. When considering these forward-looking
information and statements, readers should keep in mind the risk
factors and other cautionary statements in CannTrust's Annual
Information Form dated March 28, 2019
(the "AIF") and filed with the applicable Canadian securities
regulatory authorities on SEDAR at www.sedar.com and filed as an
exhibit CannTrust's Form 40-F annual report under the United States
Securities Exchange Act of 1934, as amended, with the United States
Securities and Exchange Commission on EDGAR at www.sec.gov (the
"March 2019 Form 40-F"). The risk
factors and other factors noted in the AIF could cause actual
events or results to differ materially from those described in any
forward-looking information or statements. Readers are also
reminded that CannTrust remains in default of its periodic
disclosure requirements under applicable securities laws and stock
exchange requirements, that its most recent AIF, Form 40-F and
other disclosures do not reflect all risk factors that currently
face the Company, and that the Company has not completed or filed
the restatements of the financial statements included in the AIF or
the March 2019 Form 40-F or otherwise
filed an amendment to such Form 40-F, and that the Company has
determined not to correct its prior filings or make any further
filings in respect of periodic disclosure requirements under
applicable securities laws and stock exchange requirements. None of
the Company's securities is listed for trading on any stock
exchange in any jurisdiction and, in Canada, trading in the Company's securities is
subject to a cease-trade order issued on April 13, 2020 by the Ontario Securities
Commission for CannTrust's failure to comply with its disclosure
obligations under applicable securities laws.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/canntrust-announces-launch-of-new-medical-brand-estora-301203333.html
SOURCE CannTrust Holdings Inc.